Overview
Compare with Brookdale Senior Living, Sonida Senior Living or Superconductor Technologies, or pick any stock.
- TickerHCSG on Nasdaq2
- IndustryServices-Nursing & Personal Care Facilities2
- HeadquartersBensalem, United States2
- Incorporated inPA3
- Business address3220 Tillman Drive, Suite 300, Bensalem, Pa 190203
- Filer categoryLarge accelerated filer3
- Legal formCorporation2
- LEI529900GVZ1D2FBYMS7192
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered address3220 Tillman Drive, Suite 300, 19020 Bensalem, United States2
- Registered withPennsylvania Department of State, 6419442
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Dietary Services brought in 55% of the revenue HEALTHCARE SERVICES GROUP INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Dietary Services | $904.7M | $950.3M | $1.0B |
| Environmental Services | $766.7M | $765.4M | $824.7M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue86¢$1.6B
- Selling, general and admin10¢$190.9M
- Income tax0¢$8.8M
- Profit3¢$59.1M
Out of $1.8B in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Capital spending4¢$5.8M
- Share buybacks42¢$61.6M
- Kept or used elsewhere54¢$77.6M
Out of $145.0M of cash from operations.4
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenues | $1.8B | $1.7B | $1.7B |
| Costs of services provided | $1.6B | $1.5B | $1.5B |
| Selling, general and administrative expenses | $190.9M | $183.1M | $166.8M |
| Investment and other income, net | $20.9M | $14.3M | $12.9M |
| Interest expense | -$1.6M | -$6.4M | -$7.9M |
| Income before taxes | $67.9M | $52.9M | $53.1M |
| Income tax provision | $8.8M | $13.5M | $14.7M |
| Net income | $59.1M | $39.5M | $38.4M |
| Basic earnings per common share (in dollars per share) | $0.82 | $0.54 | $0.52 |
| Diluted earnings per common share (in dollars per share) | $0.81 | $0.53 | $0.52 |
| Basic (in shares) | 72.4M shares | 73.8M shares | 74.3M shares |
| Diluted (in shares) | 73.0M shares | 74.0M shares | 74.3M shares |
| Unrealized gain on available-for-sale marketable securities, net of taxes | $1.9M | -$473.0K | $1.6M |
| Total comprehensive income | $60.9M | $39.0M | $40.0M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $125.2M | $56.8M | $54.3M | |
| Restricted cash equivalents | $5.6M | $3.4M | ||
| Marketable securities, at fair value | $42.8M | $50.5M | ||
| Restricted marketable securities, at fair value | $30.4M | $25.1M | ||
| Accounts receivable (less allowances: $119,305 and $87,520) | $281.3M | $330.9M | ||
| Notes receivable shortterm portion (less allowances: $25,931 and $10,372) | $31.2M | $51.4M | ||
| Inventories and supplies | $16.8M | $16.7M | ||
| Income taxes receivable | $22.2M | $0 | ||
| Prepaid expenses and other current assets | $20.9M | $21.8M | ||
| Total current assets | $576.4M | $556.7M | ||
| Property and equipment, net | $27.6M | $28.2M | ||
| Goodwill | $79.8M | $75.5M | ||
| Other intangible assets (less accumulated amortization of $42,931 and $39,242) | $7.0M | $9.4M | ||
| Notes receivable longterm portion (less allowances: $1,776 and $2,890) | $25.2M | $41.1M | ||
| Deferred compensation funding, at fair value | $55.9M | $49.6M | ||
| Deferred tax assets | $18.5M | $38.2M | ||
| Other long-term assets | $3.9M | $4.1M | ||
| Total assets | $794.3M | $802.8M | ||
| Accounts payable | $77.4M | $81.1M | ||
| Accrued payroll and related taxes | $31.4M | $51.6M | ||
| Other accrued expenses and current liabilities | $37.2M | $26.3M | ||
| Income taxes payable | $0 | $8.4M | ||
| Accrued insurance claims | $24.4M | $25.1M | ||
| Total current liabilities | $170.4M | $192.5M | ||
| Accrued insurance claims long-term | $46.1M | $51.9M | ||
| Deferred compensation liability long-term | $56.3M | $50.0M | ||
| Lease liability long-term | $9.7M | $8.0M | ||
| Other long-term liabilities | $1.6M | $385.0K | ||
| Common stock, $0.01 par value; 200,000 shares authorized; 76,821 and 76,533 shares issued, and 69,596 and 73,203 shares outstanding | $768.0K | $765.0K | ||
| Additional paid-in capital | $328.0M | $318.4M | ||
| Retained earnings | $283.7M | $224.6M | ||
| Accumulated other comprehensive loss, net of taxes | -$448.0K | -$2.3M | ||
| Common stock in treasury, at cost; 7,225 and 3,330 shares | -$101.7M | -$41.4M | ||
| Total stockholders equity | $510.2M | $499.9M | $456.6M | $418.3M |
| Total liabilities and stockholders equity | $794.3M | $802.8M | ||
| Allowance for doubtful accounts, current | $119.3M | $87.5M | ||
| Financing receivable, allowance for credit loss, current | $25.9M | $10.4M | ||
| Accumulated amortization of other intangible assets | $42.9M | $39.2M | ||
| Allowance for doubtful accounts, noncurrent | $1.8M | $2.9M | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Common stock, issued (in shares) | 76.8M shares | 76.5M shares | ||
| Common stock, outstanding (in shares) | 69.6M shares | 73.2M shares | ||
| Common stock in treasury (in shares) | 7.2M shares | 3.3M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $125.2M | $56.8M | $54.3M | |
| Restricted cash equivalents | $5.6M | $3.4M | ||
| Marketable securities, at fair value | $42.8M | $50.5M | ||
| Restricted marketable securities, at fair value | $30.4M | $25.1M | ||
| Accounts receivable (less allowances: $119,305 and $87,520) | $281.3M | $330.9M | ||
| Notes receivable shortterm portion (less allowances: $25,931 and $10,372) | $31.2M | $51.4M | ||
| Inventories and supplies | $16.8M | $16.7M | ||
| Income taxes receivable | $22.2M | $0 | ||
| Prepaid expenses and other current assets | $20.9M | $21.8M | ||
| Total current assets | $576.4M | $556.7M | ||
| Property and equipment, net | $27.6M | $28.2M | ||
| Goodwill | $79.8M | $75.5M | ||
| Other intangible assets (less accumulated amortization of $42,931 and $39,242) | $7.0M | $9.4M | ||
| Notes receivable longterm portion (less allowances: $1,776 and $2,890) | $25.2M | $41.1M | ||
| Deferred compensation funding, at fair value | $55.9M | $49.6M | ||
| Deferred tax assets | $18.5M | $38.2M | ||
| Other long-term assets | $3.9M | $4.1M | ||
| Total assets | $794.3M | $802.8M | ||
| Accounts payable | $77.4M | $81.1M | ||
| Accrued payroll and related taxes | $31.4M | $51.6M | ||
| Other accrued expenses and current liabilities | $37.2M | $26.3M | ||
| Income taxes payable | $0 | $8.4M | ||
| Accrued insurance claims | $24.4M | $25.1M | ||
| Total current liabilities | $170.4M | $192.5M | ||
| Accrued insurance claims long-term | $46.1M | $51.9M | ||
| Deferred compensation liability long-term | $56.3M | $50.0M | ||
| Lease liability long-term | $9.7M | $8.0M | ||
| Other long-term liabilities | $1.6M | $385.0K | ||
| Common stock, $0.01 par value; 200,000 shares authorized; 76,821 and 76,533 shares issued, and 69,596 and 73,203 shares outstanding | $768.0K | $765.0K | ||
| Additional paid-in capital | $328.0M | $318.4M | ||
| Retained earnings | $283.7M | $224.6M | ||
| Accumulated other comprehensive loss, net of taxes | -$448.0K | -$2.3M | ||
| Common stock in treasury, at cost; 7,225 and 3,330 shares | -$101.7M | -$41.4M | ||
| Total stockholders equity | $510.2M | $499.9M | $456.6M | $418.3M |
| Total liabilities and stockholders equity | $794.3M | $802.8M | ||
| Allowance for doubtful accounts, current | $119.3M | $87.5M | ||
| Financing receivable, allowance for credit loss, current | $25.9M | $10.4M | ||
| Accumulated amortization of other intangible assets | $42.9M | $39.2M | ||
| Allowance for doubtful accounts, noncurrent | $1.8M | $2.9M | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Common stock, issued (in shares) | 76.8M shares | 76.5M shares | ||
| Common stock, outstanding (in shares) | 69.6M shares | 73.2M shares | ||
| Common stock in treasury (in shares) | 7.2M shares | 3.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $59.1M | $39.5M | $38.4M |
| Depreciation and amortization | $16.8M | $14.6M | $14.3M |
| Bad debt provision | $83.1M | $46.8M | $35.6M |
| Deferred income taxes | $19.2M | -$2.9M | -$4.8M |
| Share-based compensation expense | $12.0M | $9.2M | $9.0M |
| Amortization of premium on marketable securities | $295.0K | $1.5M | $2.1M |
| Unrealized gain on deferred compensation fund investments | -$7.3M | -$8.2M | -$6.6M |
| Changes in other long-term liabilities | -$384.0K | -$564.0K | -$1.2M |
| Net loss on disposals of property and equipment | $422.0K | $654.0K | $818.0K |
| Share of loss from equity method investment | $2.4M | $532.0K | $0 |
| Accounts and notes receivable | $5.2M | -$61.8M | -$74.6M |
| Inventories and supplies | -$48.0K | $1.7M | $2.7M |
| Prepaid expenses and other assets | $2.6M | $704.0K | $12.8M |
| Deferred compensation funding | $318.0K | -$534.0K | -$674.0K |
| Accounts payable and other accrued expenses and current liabilities | -$12.1M | -$9.7M | $7.4M |
| Deferred ERC Credits | $12.3M | $0 | $0 |
| Accrued payroll and related taxes | -$19.2M | -$3.6M | $4.2M |
| Income taxes receivable (payable) | -$30.6M | $1.2M | $572.0K |
| Accrued insurance claims | -$6.5M | -$7.4M | -$4.3M |
| Deferred compensation liability | $7.4M | $9.2M | $7.8M |
| Net cash from operating activities | $145.0M | $30.8M | $43.5M |
| Proceeds from disposals of property and equipment | $105.0K | $211.0K | $121.0K |
| Additions to property and equipment | -$5.8M | -$6.3M | -$5.4M |
| Cash paid for acquisition | -$7.2M | $0 | $0 |
| Cash paid for investments | -$2.6M | -$2.8M | $0 |
| Purchases of marketable securities | -$18.7M | -$52.1M | $0 |
| Sales of marketable securities | $23.2M | $67.0M | $2.0M |
| Net cash from investing activities | -$11.0M | $6.0M | -$3.3M |
| Purchases of treasury stock | -$61.6M | -$5.0M | -$11.3M |
| Repayments of short-term borrowings | $0 | -$25.0M | $0 |
| Payments of statutory withholding on net issuance of common stock | -$1.7M | -$1.0M | -$871.0K |
| Net cash from financing activities | -$63.3M | -$31.0M | -$12.2M |
| Net increase in cash, cash equivalents, and restricted cash equivalents | $70.6M | $5.8M | $28.1M |
| Cash paid for interest | $1.7M | $6.5M | $7.8M |
No quarter-by-quarter statement was filed.
Corporate structure
HEALTHCARE SERVICES GROUP INC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of HEALTHCARE SERVICES GROUP INC
- MACKENZIE FINANCIAL CORP Filed SCHEDULE 13G/A on HEALTHCARE SERVICES GROUP INC, latest May 15, 2026 (10 filings since Feb 4, 2022)
- VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on HEALTHCARE SERVICES GROUP INC, latest Apr 30, 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on HEALTHCARE SERVICES GROUP INC, latest Apr 29, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on HEALTHCARE SERVICES GROUP INC, latest Mar 27, 2026 (4 filings since Feb 10, 2022)
- ROYCE & ASSOCIATES LP Filed SCHEDULE 13G/A on HEALTHCARE SERVICES GROUP INC, latest Jul 16, 2025 (3 filings since Jan 23, 2024)
- BlackRock Filed SCHEDULE 13G/A on HEALTHCARE SERVICES GROUP INC, latest Apr 28, 2025 (7 filings since Feb 7, 2022)
- Invesco Filed SC 13G/A on HEALTHCARE SERVICES GROUP INC, latest Feb 1, 2024 (2 filings since Feb 10, 2023)
- State Street Corporation Filed SC 13G/A on HEALTHCARE SERVICES GROUP INC, latest Jan 22, 2024 (2 filings since Feb 1, 2023)
- RIVERBRIDGE PARTNERS LLC Filed SC 13G/A on HEALTHCARE SERVICES GROUP INC, latest Jan 21, 2022
- HEALTHCARE SERVICES GROUP INC Bensalem, Pennsylvania, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What HEALTHCARE SERVICES GROUP INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $125.2M4 Dec 31, 2025 | $56.8M4 Dec 31, 2024 | +120.5% |
| Marketable securities, current | $42.8M4 Dec 31, 2025 | $50.5M4 Dec 31, 2024 | −15.4% |
| Debt securities available for sale | $73.1M4 Dec 31, 2025 | $75.6M4 Dec 31, 2024 | −3.3% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $79.8M4 Dec 31, 2025 | $75.5M4 Dec 31, 2024 | +5.7% |
| Finite-lived intangibles, gross | $49.9M4 Dec 31, 2025 | $48.7M4 Dec 31, 2024 | +2.5% |
| Accumulated amortization | $42.9M4 Dec 31, 2025 | $39.2M4 Dec 31, 2024 | +9.4% |
| Finite-lived intangibles, net | $7.0M4 Dec 31, 2025 | $9.4M4 Dec 31, 2024 | −26.2% |
Properties, in its own words
We lease our corporate offices, located at 3220 Tillman Drive, Suite 300, Bensalem, Pennsylvania 19020. The Pennsylvania office is the headquarters of Healthcare Services Group, Inc., ELuminate, LLC and Platinum Cleaning Services of Indianapolis, LLC. We also lease office space at other locations in Connecticut, Florida, New Jersey, Texas and Virginia. The New Jersey office is the headquarters of HCSG Insurance Corp (“HCSG Insurance”), our captive insurance company, as well as HCSG East, LLC, HCSG West, LLC, HCSG Central, LLC, HCSG Staff Leasing Solutions, LLC, HCSG Labor Supply, LLC, HCSG East Labor Supply, LLC, and HCSG Clinical Services, LLC. The Virginia office is the headquarters of Meriwether-Godsey, Inc. The other locations serve as divisional or regional offices providing management and administrative services to both of our operating segments in their respective geographical areas. No individual parcel of real estate owned or leased is of material significance to our total assets.
Management does not foresee any difficulties with regard to the continued utilization of these premises. We also believe that such properties are sufficient to support our current operations.
Item 2 of the 10-K filed Feb 13, 2026.12
Leadership
Who has led HEALTHCARE SERVICES GROUP INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerTheodore Wahl Aug 3, 2015 to now13
- Chief executive officerDaniel P. McCartney Jan 5, 2006 to Jan 6, 201514
- ChairDaniel P. McCartney Jan 22, 2007 to Jan 22, 200715
- PresidentTheodore Wahl Jan 8, 2013 to now16
- Chief financial officerVikas Singh Sep 11, 2024 to now17
- Chief financial officerJohn Christopher Shea Jan 8, 2013 to Jan 5, 202218
- Chief financial officerRichard W. Hudson Apr 27, 2007 to Mar 12, 201219
- Chief financial officerJames L. Distefano Jan 5, 2006 to May 4, 200720
- Chief operating officerAndrew Kush Dec 4, 2020 to now21
- Chief operating officerDavid Hurlock Jul 21, 2017 to Jan 4, 201922
- Chief operating officerTheodore Wahl Sep 26, 2011 to Jan 5, 201523
Board members and other officers (25)
- EVP & Chief Revenue OfficerPatrick J. Orr Jan 4, 2021 to now24
- EVP/Gen. Counsel/Corp. Secty.Jason J. Bundick Jan 6, 2021 to now25
- Acting Accounting OfficerAndrew M. Brophy Mar 8, 2021 to now26
- Executive Vice PresidentAndrew Kush Apr 21, 2017 to Jan 6, 202027
- Executive Vice PresidentBryan D. McCartney Apr 9, 2012 to Feb 14, 201728
- Sr VP of OperationsMichael E. McBryan May 27, 2011 to Nov 16, 202029
- Chief Accounting OfficerJohn Christopher Shea Oct 7, 2010 to now30
- Vice President FinanceTheodore Wahl Jan 16, 2009 to Jan 7, 201131
- Vice PresidentJoseph F. McCartney Jan 5, 2006 to Jan 8, 201332
- Vice PresidentRichard W. Hudson Jan 5, 2006 to Jun 15, 201233
- Board memberThomas Gerard Whalen Jun 4, 2025 to now34
- Board memberKurt Simmons Jr. Nov 10, 2021 to now35
- Board memberLaura K. Grant May 29, 2020 to now36
- Board memberDaniela Castagnino Jun 8, 2018 to now37
- Board memberJude Visconto Jun 16, 2015 to now38
- Board memberDiane S. Casey May 27, 2011 to now39
- Board memberMichael E. McBryan May 27, 2011 to Feb 5, 202129
- Board memberTheodore Wahl Sep 26, 2011 to now23
- Board memberRobert J. Moss Jun 15, 2007 to Jan 6, 202040
- Board memberDino D. Ottaviano Jun 19, 2007 to now41
- Board memberDaniel P. McCartney Jan 5, 2006 to May 15, 201714
- Board memberJoseph F. McCartney Jan 5, 2006 to Jan 8, 201332
- Board memberBarton D. Weisman Feb 22, 2006 to Apr 29, 200942
- Board memberRobert L. Frome Jul 27, 2006 to now43
- General counselJason J. Bundick Dec 19, 2013 to Jan 6, 202044
Timeline
- Oct 7, 20268-K Entered a material agreement; Regulation FD disclosure45
- Jul 22, 20268-K Results of operations46
- May 27, 20268-K Shareholder vote47
- Apr 22, 20268-K Results of operations48
- Apr 13, 20268-K Entered a material agreement; New debt or obligation49
- Feb 11, 20268-K Results of operations50
- Oct 22, 20258-K Results of operations51
- Jul 23, 20258-K Results of operations52
- Jul 10, 20258-K Regulation FD disclosure53
- May 28, 20258-K Shareholder vote54
- Apr 23, 20258-K Results of operations55
- Feb 12, 20258-K Results of operations56
- Aug 3, 2015New chief executive Theodore Wahl becomes CEO13
- Jan 5, 2006New chief executive Daniel P. McCartney becomes CEO14
Calendar
Coming up
- Oct 21, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $0.23 a share, on Oct 22, 2025.57
When it reported results
- Jul 22, 2026Reported quarterly or annual results46
- Apr 22, 2026Reported quarterly or annual results48
- Feb 11, 2026Reported quarterly or annual results50
- Oct 22, 2025Reported quarterly or annual results51
- Jul 23, 2025Reported quarterly or annual results52
- Apr 23, 2025Reported quarterly or annual results55
- Feb 12, 2025Reported quarterly or annual results56
- Oct 23, 2024Reported quarterly or annual results58
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
278 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 35 major events, 159 insider forms, 31 large holders, 33 other. The latest 20:
- Oct 7, 20268-K EDGAR
- Oct 1, 20264 EDGAR
- Oct 1, 20264 EDGAR
- Oct 1, 20264 EDGAR
- Aug 5, 20264 EDGAR
- Aug 4, 2026144 EDGAR
- Jul 24, 2026S-8 EDGAR
- Jul 24, 202610-Q EDGAR
- Jul 22, 20268-K EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- May 29, 20264/A EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
- May 28, 20264 EDGAR
The 278 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
11 open-market trades by officers, directors and large owners since October 2021: 1 buys and 10 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Kush AndrewEVP & Chief Operating Officer | Sale | 15,598 | $23.24 | $362.5K | Form 4 |
| Feb 26, 2026 | Brophy Andrew MSVP & Chief Accounting Officer | Sale | 2,490 | $21.75 | $54.2K | Form 4 |
| Feb 18, 2026 | Orr Patrick JEVP & Chief Revenue Officer | Sale | 44,615 | $20.53 | $915.8K | Form 4 |
| Feb 18, 2026 | Orr Patrick JEVP & Chief Revenue Officer | Sale | 45,500 | $20.54 | $934.6K | Form 4 |
| Feb 18, 2026 | SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer | Sale | 54,357 | $20.41 | $1.1M | Form 4 |
| Jul 28, 2025 | SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer | Sale | 21,368 | $13.25 | $283.1K | Form 4 |
| Feb 26, 2025 | Brophy Andrew MSVP & Chief Accounting Officer | Sale | 1,744 | $10.45 | $18.2K | Form 4 |
| Feb 28, 2024 | Brophy Andrew MSVP & Chief Accounting Officer | Sale | 1,125 | $12.58 | $14.2K | Form 4 |
| Jun 30, 2023 | Simmons Kurt JRDirector | Buy | 1,005 | $14.93 | $15.0K | Form 4 |
| Feb 24, 2023 | Brophy Andrew MSVP & Chief Accounting Officer | Sale | 951 | $13.41 | $12.8K | Form 4 |
| Nov 23, 2021 | BRIGGS JOHNDirector | Sale | 5,001 | $18.71 | $93.6K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- MACKENZIE FINANCIAL CORPSCHEDULE 13G/A, 10 filings Feb 4, 2022 to May 15, 202659
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202660
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202661
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 10, 2022 to Mar 27, 202662
- ROYCE & ASSOCIATES LPSCHEDULE 13G/A, 3 filings Jan 23, 2024 to Jul 16, 202563
- BlackRockSCHEDULE 13G/A, 7 filings Feb 7, 2022 to Apr 28, 202564
- InvescoSC 13G/A, 2 filings Feb 10, 2023 to Feb 1, 202465
- State Street CorporationSC 13G/A, 2 filings Feb 1, 2023 to Jan 22, 202466
- RIVERBRIDGE PARTNERS LLCSC 13G/A, 1 filing Jan 21, 202267
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Theodore Wahl | $1.0M | $4.7M68 | |
| 2025 | Andrew W. Kush | $651.3K | $1.6M68 | |
| 2025 | John C. Shea | $618.4K | $1.5M68 | |
| 2025 | Patrick J. Orr | $591.3K | $1.4M68 | |
| 2025 | Vikas Singh5 | $579.0K | $1.3M68 | |
| 2024 | President & ChiefExecutive Officer & Director | $1.0M | $4.7M68 | |
| 2024 | Executive VicePresident & Chief Financial Officer | $153.8K | $165.5K68 | |
| 2023 | President & ChiefExecutive Officer & Director | $1.0M | $4.6M68 | |
| 2023 | Executive VicePresident & Chief Operating Officer | $639.0K | $1.5M68 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 11,375,365 | $279.4M | 0.0% | −83,231 |
| Vanguard Portfolio Management LLC | 5,080,313 | $124.8M | 0.0% | +234,180 |
| Vanguard Capital Management LLC | 3,040,374 | $74.7M | 0.0% | −79,171 |
| State Street Corp | 2,916,008 | $71.6M | 0.0% | +96,883 |
| American Century Companies Inc | 2,661,455 | $65.4M | 0.0% | +153,028 |
| Geode Capital Management, LLC | 2,562,011 | $62.9M | 0.0% | +517,415 |
| Dimensional Fund Advisors LP | 2,484,818 | $61.0M | 0.0% | +84,137 |
| Fmr LLC | 2,296,772 | $56.4M | 0.0% | +329,978 |
| Ameriprise Financial Inc | 2,255,190 | $55.4M | 0.0% | +89,446 |
| Royce & Associates LP | 2,239,224 | $55.0M | 0.4% | +95,987 |
| Arrowstreet Capital, Limited Partnership | 1,443,054 | $35.4M | 0.0% | +37,102 |
| Franklin Resources Inc | 1,244,416 | $30.6M | 0.0% | +83,194 |
| Charles Schwab Investment Management Inc | 1,165,139 | $28.6M | 0.0% | −158,133 |
| Nuveen, LLC | 1,127,400 | $27.7M | 0.0% | −45,004 |
| First Eagle Investment Management, LLC | 1,096,070 | $26.9M | 0.0% | +621,535 |
| Morgan Stanley | 1,049,627 | $25.8M | 0.0% | +38,903 |
| Pembroke Management, LTD | 1,046,450 | $25.7M | 1.8% | +747,365 |
| Invesco Ltd. | 994,507 | $24.4M | 0.0% | +168,237 |
| Aqr Capital Management LLC | 974,997 | $23.7M | 0.0% | −112,483 |
| Goldman Sachs Group Inc | 962,865 | $23.6M | 0.0% | −225,552 |
| Qube Research & Technologies Ltd | 941,010 | $23.1M | 0.0% | −56,098 |
| Jupiter Topco LLC | 912,261 | $22.4M | 0.0% | New |
| Mackenzie Financial Corp | 856,834 | $21.0M | 0.0% | −1,815,380 |
| Marathon Asset Management Ltd | 759,824 | $18.7M | 0.8% | −211,643 |
| Northern Trust Corp | 743,729 | $18.3M | 0.0% | +69,503 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
1 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Apr 30, 2020 | Greg Gianforte, House | Buy | $50,001 - $100,000 | −181.6% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How HEALTHCARE SERVICES GROUP INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARHEALTHCARE SERVICES GROUP INC1
- CIK0000731012
- Employer ID (EIN)23-201836512
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company12
- Incorporated inPennsylvania12
- Fiscal year endsDecember 311
- Industry code (SIC)8050 Services-Nursing & Personal Care Facilities1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address3220 Tillman Drive, Suite 300, Bensalem, PA 190201
- Phone21593816611
- Shares outstanding68,632,202 as of Jul 22, 202610
- Public float$897.0M as of Jun 30, 202512
- AuditorGRANT THORNTON LLP, Philadelphia, Pennsylvania PCAOB ID 248; it also attests to the company’s internal control over financial reporting12
- On EDGAR sinceJan 21, 19941
- Filings1,335 in all: 4 (734), 8-K (145), SC 13G/A (117), 10-Q (95), SC 13G (41), DEF 14A (32), 10-K (29), UPLOAD (21)1
All 33 form types
3 (19), CORRESP (14), 11-K (13), 4/A (12), S-8 (11), SCHEDULE 13G/A (9), 144 (7), ARS (4), PRE 14A (4), S-8 POS (4), S-3 (3), 10-K405 (2), 424B3 (2), 5 (2), DEFA14A (2), EFFECT (2), S-3ASR (2), SCHEDULE 13G (2), 15-12G (1), 8-K/A (1), DEFR14A (1), NT 10-K (1), NT 10-Q (1), RW (1), S-3D (1)
- Latest filingsAnnual report (10-K) Feb 13, 2026
Quarterly report (10-Q) Jul 24, 2026
Proxy statement (DEF 14A) Apr 15, 2026
Latest 8-K (8-K) Oct 7, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.01 par value | HCSG | Nasdaq Global Select Market |
From the cover page of the 10-K filed Feb 13, 2026 (Section 12(b) of the Exchange Act).12
Risk factors and legal proceedings
The risks HEALTHCARE SERVICES GROUP INC names in Item 1A of its 10-K filed Feb 13, 2026: 22 risks under these headings, as written.12
- Risks Related to Macroeconomic Conditions
- We have been, and may continue to be, adversely affected by inflationary and market fluctuations, including the impact of potential future tariffs, impacting the cost of products consumed in providing our services and our cost of labor. Additionally, we rely on a certain limited number of vendors for a substantial portion of EVS and Dietary supplies.
- Pandemics, epidemics or outbreaks of a contagious illness have in the past and may in the future adversely affect our business, results of operations, financial condition, and/or cash flows.
- War, terrorism, other acts of violence or natural or man-made disasters may affect the markets in which the Company operates, the Company’s customers, and could have a material adverse impact on our business, results of operations, financial condition and/or cash flows.
- Changes in interest rates and financial market conditions have resulted in and may continue to result in fluctuating and even negative returns in our investments and could increase the cost of the borrowings under our borrowing agreements.
- Risks Related to Customers and Distributors
- We provide services to several customers which contribute significantly, on an individual as well as an aggregate basis, to our total revenues.
- Our customers are primarily concentrated in the healthcare industry, which is subject to changes in government regulation. Many of our customers rely on reimbursement from Medicare, Medicaid and other third-party payers. Rates from such payers may be altered or reduced, thus affecting our customers’ results of operations and cash flows.
- The Company has substantial investment in the creditworthiness and financial condition of our customers.
- A significant majority of our customer base are multi-facility management groups and independent facility operators who lease the buildings in which they operate and may experience risks relating to their leases including termination, escalators, extensions and special charges.
- For the year ended December 31, 2025, one distributor distributed more than 50% of our food and non-food dining supplies, and if our relationship, or its business, were to be disrupted, we could experience disruptions to our operations and cost structure.
- Risks Related to Operating Our Business
The other 13 risks
- We have a Paid Loss Retrospective Insurance Plan for general liability, workers’ compensation and other insurance coverages.
- We primarily provide our services pursuant to agreements cancellable by either party upon 30 to 90 days’ notice after an initial 60 to 120 day service agreement period.
- The Company’s business success depends on the management experience of our key personnel.
- Any perceived or real health risks related to the food industry could adversely affect our Dietary segment.
- If we fail to develop and maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired.
- Our business could be negatively affected as a result of actions of activist shareholders, and such activism could impact the trading value of our securities.
- Risks Related to Governmental and Regulatory Changes
- Changes to federal healthcare legislation may adversely affect our operating costs and results of operations.
- States in which our customers are located could experience significant budget deficits and such deficits may result in reduction of reimbursements to nursing homes.
- Governmental regulations related to labor, employment, immigration and health and safety could adversely impact our business, results of operations, financial condition and cash flows.
- Federal, state and local tax rules can adversely impact our business, results of operations, financial position and cash flows.
- Our business and financial results could be adversely affected by unfavorable results of material litigation or governmental inquiries.
- Stakeholder expectations for and compliance with federal and state environmental, social and governance (“ESG”) requirements can adversely impact our business, results of operations, financial position and cash flows.
- Risks Related to Technology, Cybersecurity, Data Privacy and Artificial Intelligence
- We have experienced a cyber-attack and breach, and may in the future experience cyber-attacks, breaches or other events which could cause operational disruptions, fraud or theft of sensitive information.
Legal proceedings
In the normal course of business, the Company is involved in various administrative and legal proceedings, including labor and employment, contracts, personal injury and insurance matters.
At this time, the Company is unable to reasonably estimate possible losses or form a judgment that an unfavorable outcome is either probable, reasonably possible or remote with respect to certain pending litigation claims asserted.
In light of the uncertainties involved in such proceedings, the ultimate outcome of a particular matter could become material to the Company’s results of operations for a particular period depending on, among other factors, the size of the loss or liability imposed and the level of the Company’s operating income for that period.
The opening of Item 3, Legal Proceedings.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARDaniel P. McCartney, Chair
- 16SEC EDGARTheodore Wahl, President
- 17SEC EDGARVikas Singh, Chief financial officer
- 18
- 19
- 20
- 21SEC EDGARAndrew Kush, Chief operating officer
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32SEC EDGARJoseph F. McCartney, Vice President
- 33SEC EDGARRichard W. Hudson, Vice President
- 34SEC EDGARThomas Gerard Whalen, Board member
- 35SEC EDGARKurt Simmons Jr., Board member
- 36SEC EDGARLaura K. Grant, Board member
- 37SEC EDGARDaniela Castagnino, Board member
- 38SEC EDGARJude Visconto, Board member
- 39SEC EDGARDiane S. Casey, Board member
- 40SEC EDGARRobert J. Moss, Board member
- 41SEC EDGARDino D. Ottaviano, Board member
- 42SEC EDGARBarton D. Weisman, Board member
- 43SEC EDGARRobert L. Frome, Board member
- 44SEC EDGARJason J. Bundick, General counsel
- 45
- 46SEC EDGARResults of operations
- 47SEC EDGARShareholder vote
- 48SEC EDGARResults of operations
- 49
- 50SEC EDGARResults of operations
- 51SEC EDGARResults of operations
- 52SEC EDGARResults of operations
- 53SEC EDGARRegulation FD disclosure
- 54SEC EDGARShareholder vote
- 55SEC EDGARResults of operations
- 56SEC EDGARResults of operations
- 57NasdaqNasdaq calendar
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68